Lymph Node Metastases Clinical Trials

9 recruiting

Lymph Node Metastases Trials at a Glance

9 actively recruiting trials for lymph node metastases are listed on ClinicalTrialsFinder across 6 cities in 15 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Leiden, Milan, and Eindhoven. Lead sponsors running lymph node metastases studies include Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Canisius-Wilhelmina Hospital, and AC Camargo Cancer Center.

Browse lymph node metastases trials by phase

Treatments under study

About Lymph Node Metastases Clinical Trials

Looking for clinical trials for Lymph Node Metastases? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lymph Node Metastases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lymph Node Metastases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

Prostate CancerLymph Node MetastasesProstate Cancer Metastatic
Canisius-Wilhelmina Hospital706 enrolled1 locationNCT05000827
Recruiting
Not Applicable

Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy

Breast CancerSurgeryLymph Node Metastases
Second Affiliated Hospital, School of Medicine, Zhejiang University126 enrolled1 locationNCT04744506
Recruiting
Not Applicable

Sentinel Node Mapping in High Risk Endometrial Cancer

Endometrial CancerLymph Node Metastases
AC Camargo Cancer Center178 enrolled5 locationsNCT03366051
Recruiting

Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma

Lymph Node MetastasesDifferentiated Thyroid Cancer
Soroka University Medical Center250 enrolled5 locationsNCT05078853
Recruiting

Distribution of Lymph Node Metastases in Esophageal Carcinoma

Lymph Node MetastasesEsophageal Neoplasms
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)5,000 enrolled19 locationsNCT03222895
Recruiting
Phase 2

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Sentinel Lymph NodeLymph Node MetastasesVulvar Cancer
University Medical Center Groningen157 enrolled27 locationsNCT05076942
Recruiting
Not Applicable

Lymph Node Mapping Via Flourescent Dye in Colon Cancer

Lymph Node MetastasesColon Carcinoma
Universitätsklinikum Hamburg-Eppendorf30 enrolled1 locationNCT04959604
Recruiting

Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer

Breast CancerNeoadjuvant TherapyLymph Node Metastases
Maastricht University Medical Center549 enrolled35 locationsNCT04486495
Recruiting

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.

Cervical CancerEndometrial CancerSentinel Lymph Node+8 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano500 enrolled1 locationNCT04403867